Role of serum-derived hyaluronan-associated protein-hyaluronan complex in ovarian cancer

Oncology Reports

Volumn 19, Issue 5, 2008, Pages 1245-1251

  Obayashi, Yukihiko ^a   Yabushita, Hiromitsu ^a   Kanyama, Kouhei ^a   Noguchi, Mari ^a   Zhuo, Lisheng ^a   Kimata, Koji ^a   Wakatsuki, Akihiko ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hyaluronan; Metalloproteinase; Metastasis; Ovarian cancer; SHAP HA complex

Indexed keywords

GELATINASE A; GELATINASE B; HYALURONIC ACID; HYALURONIC ACID ASSOCIATED PROTEIN; HYALURONIC ACID DERIVATIVE; METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; ULINASTATIN; UNCLASSIFIED DRUG; ALPHA GLOBULIN; GLYCOPROTEIN; INTER ALPHA INHIBITOR; INTER-ALPHA-INHIBITOR;

ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOUBLE ANTIBODY SANDWICH ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; METASTASIS; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; ADULT; AGED; BIOSYNTHESIS; CASE CONTROL STUDY; CHEMISTRY; FEMALE; GENE EXPRESSION REGULATION; METABOLISM; MIDDLE AGED; OVARY TUMOR; PATHOLOGY; PHYSIOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-GLOBULINS; CASE-CONTROL STUDIES; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HUMANS; HYALURONIC ACID; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM METASTASIS; OVARIAN NEOPLASMS;

EID: 47549110789     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.19.5.1245     Document Type: Article

References (41)

1. Zetter BR: Adhesion molecules in tumor metastasis. Semin Cancer Biol 4: 219-229, 1993.
2. Toole B: Glycosaminoglycans in morphogenesis. In: Cell Biology of the Extracellular Matrix. Hay E (ed). Plenum Press, New York, pp259-294, 1982.
3. Mast BA, Diegelmann RF, Krummel TM and Cohen IK: Scarless wound healing in the mammalian fetus. Surg Gynecol Obstet 174: 441-451, 1992.
4. Zhang L, Underhill CB; and Chen L: Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer Res 55: 428-433, 1995.
5. Kimata K, Honma Y, Okayama M, Oguri K, Hozumi M and Suzuki S: Increased synthesis of hyaluronic acid by mouse mammary carcinoma cell variants with high metastatic potential. Cancer Res 45: 5098-5105, 1985.
6. Turley EA and Tretiak M: Glycosaminoglycan production by murine melanoma variants in vivo and in vitro. Cancer Res 43: 1347-1354, 1983.
7. Knudson W: Tumor-associated hyaluronan. Am J Pathol 148: 1721-1726, 1996.
8. McBride WH and Brad JBL: Hyaluronidase-sensitive halos around adherent cells: their role in blocking lymphocyte-mediated cytolysis. J Exp Med 149: 507-515, 1979.
9. Toole BP: Hyaluronan and its binding protein, the hyaladherins. Curr Opin Cell Biol 2: 839-844, 1990.
10. Underhill C: CD44: the hyaluronan receptor. J Cell Sci 103: 293-298, 1992.
11. Masselis-Smith A, Belch AR, Mant MJ, Turley EA and Pilarski LM: Hyaluronan-dependent motility of B cells and leukemic plasma cells in blood, but not of bone marrow plasma cells, in multiple myeloma: alternate use of receptor for hyaluronan-mediated motility (RHAMM) and CD44. Blood 5: 1891-1899, 1996.
12. Jackson RL, Busch SJ and Cardin AD: Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol Rev 71: 481-539, 1991.
13. Yoneda M, Suzuki S and Kimata K: Hyaluronic acid associated with the surfaces of cultured fibroblasts is linked to a serum-derived 85-kDA protein. J Biol Chem 265: 5247-5257, 1990.
14. Zhao M, Yoneda M, Ohashi Y, Kurono S, Iwata H and Kimata K: Evidence for the covalent binding of SHAP, heavy chains of inter-α-trypsin inhibitor, to hyaluronan. J Biol Chem 270: 26657-26663, 1995.
15. Huang L, Yoneda M and Kimata K: A serum-derived hyaluronan-associated protein (SHAP) is the heavy chain of the inter-α-trypsin Inhibitor. J Biol Chem 268: 26725-26730, 1993.
16. 2 heavy chains. J Immunol Methods 190: 61-70, 1996.
17. Salier JP: Inter-α-trypsin inhibitor: emergence of a family within the Kunitz-type protease inhibitor superfamily. Trends Biochem Sci 15: 435-439, 1990.
18. Zhuo L, Yoneda M, Zhao M, Yingsung W, Yoshida N, Kitagawa Y, Kawamura K, Suzuki T and Kimata K: Defect in SHAP-hyaluronan complex causes severe female infertility. A study by inactivation of the bikunin gene in mice. J Biol Chem 276: 7693-7696, 2001.
19. Isnard N, Legeais JM, Renard G and Robert L: Effect of hyaluronan on MMP expression and activation. Cell Biol Int 25: 735-739, 2001.
20. Sillanpaa S, Anttila M, Voutilainen K, Ropponen K, Turpeenniemi-Hujanen T, Puistola U, Tammi M, Sironen R, Saarikoski S and Kosma VN: Prognostic significance of matrix metalloproteinase-9 (MMP-9) in epithelial ovarian cancer. Gynecol Oncol 104: 296-303, 2007.
21. Wannarat Y, Lisheng Z, Matthias M, Yoneda M, Kida D and Kimata K: Molecular heterogeneity of the SHAP-hyaluronan complex. J Biol Chem 278: 32710-32718, 2003.
22. Fujimoto M, Mouri N, Iwata K, Ohuchi E, Okada Y and Hayakawa T: A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies. Clin Chim Acta 221: 91-103, 1993.
23. Fujimoto M, Hosokawa N, Iwata K, Shinya T, Okada Y and Hayakawa T: A one-step sandwich enzyme immunoassay for inactive precursor and complexed forms of human matrix metalloproteinase 9 (92-kDa gelatinase/ type IV collagenase) using monoclonal antibodies. Clin Chim Acta 231: 79-88, 1994.
24. Kodama S, Iwata K, Iwata H, Yamashita K and Hayakawa T: Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases. An application for rheumatoid arthritis serum and plasma. J Immunol Methods 127: 103-108, 1990.
25. Narumiya H, Yabushita H, Hirata M, Matsushita S, Noguchi M and Nakanishi M: Increased levels of serum matrix metallo-proteinase-9 and its regulators as tumor stage markers in ovarian cancer patients. J Aichi Med Univ Assoc 27: 255-260, 1999.
26. Yabushita H, Noguchi M, Obayashi Y, Kishida T, Noguchi Y, Sawaguchi K and Noguchi M: Angiostatin expression in ovarian cancer. Oncol Rep 10: 1225-1230, 2003.
27. Yabushita H, Shimazu M, Noguchi M, Kishida T, Narumiya H, Sawagucbi K and Noguchi M: Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer. Oncol Rep 10: 89-95, 2003.
28. Auvinen PK, Parkkinen JJ, Agren U, Johansson RT, Tammi RH, Eskelinen MJ and Kosma V-M. Expression of hyaluronan in benign and malignant breast lesions. Int J Cancer 74: 477-481, 1997.
29. Ropponen K, Tammi M, Parkkinen JJ, Eskelinen M, Tammi R, Lipponen P, Agren U, Alhava E and Kosma V-M: Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. Cancer Res 58: 342-347, 1998.
30. Dahl IMS and Laurent TCC: Concentration of hyaluronan in serum of untreated cancer patients with special reference to patients with mesothelioma. Cancer 62: 326-330, 1988.
31. Ishimoto N, Temin HM and Strominger JL: Studies of carcino-genesis by avian sarcoma virus. II. Virus-induced increase in hyaluronic acid synthetase in chicken fibroblasts. J Biol Chem 241: 2052-2057, 1996.
32. Bader JP: Temperature-dependent transformation of cells infected with a mutant of Bryan Rous sarcoma virus. J Virol 10: 267-276, 1972.
33. Hopwood JJ and Dorfmann A: Glycosaminoglycan synthesis by cultured human skin fibroblasts after transformation with simian virus 40. J Biol Chem 252: 4777-4785, 1977.
34. Toole BP, Biswas C and Gross J:Hyaluronate and invasiveness of the rabbit V2 carcinoma. Proc Natl Acad Sci USA 76: 6299-6303, 1979.
35. Laurent TC and Fraser JR: Hyaluronan. FASEB J 6: 2397-2404, 1992.
36. Knudson CB and Knudson W: Hyaluronan-binding proteins in development, tissue homeostasis and disease. FASEB J 7: 1233-1241, 1993.
37. West DC, Hampson IN, Arnold F and Kumar S: Angiogenesis induced by degradation products of hyaluronic acid. Science 228: 1324-1326, 1985.
38. Yabushita H, Noguchi M, Kishida T, Fusano K, Noguchi Y, Itano N, Kimata K and Noguchi M: Hyaluronan synthase expression in ovarian cancer. Oncol Rep 12:739-743, 2004.
39. Yamada Y, Itano N, Narimatsu H, Kudo T, Morozumi K, Hirohashi S, Ochiai A, Ueda M and Kimata K: Elevated transcript level of hyaluronan synthase1 gene correlates with poor prognosis of human colon cancer. Clin Exp Metastasis 21:57-63, 2004.
40. Anttila MA, Tammi RH, Tammi MI, SyrJanen KJ, Saarikoski SV and Kosma VM: High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer. Cancer Res 60: 150-155, 2000.
41. Kayastha S, Freedman AN, Piver MS, Mukkamalla J, Romero-Guittierez M and Werness BA: Expression of the hyaluronan receptor, CD44S, in epithelial ovarian cancer is an independent predictor of survival. Clin Cancer Res 5: 1073-1076, 1999.